S O'Brien
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 19
- Chronic Lymphocytic Leukemia Research 18
- Hematology 10
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Charles Koller (7 shared papers)Hagop M. Kantarjian (9 shared papers)Michael J. Keating (6 shared papers)Elihu H. Estey (7 shared papers)Miloslav Beran (4 shared papers)MJ Keating (6 shared papers)M Keating (7 shared papers)L. E. Robertson (4 shared papers)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (7 papers)Leukemia (3 papers)Haematologica (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
S O'Brien
35 papers receiving 2.2k citations
S O'Brien's Hit Papers
Peers
Comparison fields: 5 of 74
- Genetics 1.1k
- Hematology 972
- Pathology and Forensic Medicine 786
- Immunology 635
- Oncology 447
Countries citing papers authored by S O'Brien
This map shows the geographic impact of S O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S O'Brien more than expected).
Fields of papers citing papers by S O'Brien
This network shows the impact of papers produced by S O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S O'Brien. The network helps show where S O'Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside S O'Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Hit paper breakdown → | 1998 | 737 |
| 2 | 1993 | 232 | |
| 3 | 1993 | 195 | |
| 4 | 1993 | 186 | |
| 5 | 1993 | 148 | |
| 6 | 1996 | 103 | |
| 7 | 1997 | 92 | |
| 8 | 1992 | 89 | |
| 9 | 2022 | 70 | |
| 10 | 2015 | 60 | |
| 11 | 2016 | 52 | |
| 12 | 1987 | 46 | |
| 13 | 1992 | 42 | |
| 14 | 1989 | 30 | |
| 15 | 1998 | 26 | |
| 16 | 1993 | 20 | |
| 17 | 1986 | 19 | |
| 18 | 2011 | 16 | |
| 19 | 1988 | 14 | |
| 20 | 1995 | 13 |
About S O'Brien
S O'Brien is a scholar working on Genetics, Hematology, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 36 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Neutropenia and Cancer Infections (4 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Genetics (1.1k citations), Hematology (972 citations), Pathology and Forensic Medicine (786 citations), Immunology (635 citations) and Oncology (447 citations). S O'Brien has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Charles Koller, Hagop M. Kantarjian, Michael J. Keating, Elihu H. Estey, Miloslav Beran, MJ Keating, M Keating, L. E. Robertson, Cindy Ippoliti and Richard E. Champlin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.